A new gene therapy to treat melanoma
A novel gene-based immunotherapy inducing melanoma destruction
This study is testing a new treatment for melanoma that uses your own immune system to help fight the cancer, and it’s looking for patients who want to try this exciting approach.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-11056101 on NIH RePORTER |
What this research studies
This research investigates a novel gene-based immunotherapy aimed at destroying melanoma cells. It utilizes autologous melanoma vaccines that harness the body's own anti-a-Gal antibodies to enhance the immune response against tumor-specific antigens. By improving the immunogenicity of these antigens, the therapy seeks to activate the immune system more effectively to target and eliminate melanoma cells. Patients may have the opportunity to participate in trials that explore this innovative approach to melanoma treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with advanced melanoma who have not responded to existing therapies.
Not a fit: Patients with early-stage melanoma or those who have not been diagnosed with melanoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new and effective treatment option for patients with advanced melanoma.
How similar studies have performed: While the use of gene-based immunotherapies is a growing field, this specific approach utilizing anti-a-Gal antibodies is novel and has not been extensively tested in melanoma treatment.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Michael, Katja — University of Texas El Paso
- Study coordinator: Michael, Katja
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.